Eyenovia Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Eyenovia Stock Summary

Eyenovia competes with ZyVersa Therapeutics, Sonnet Biotherapeutics, Zura Bio, Phio Pharmaceuticals, and Transcode Therapeutics. Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. Eyenovia, Inc. was incorporated in 2014 and is headquartered in New York, New York. Eyenovia operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 43 people.

Eyenovia Key Financial Ratios

Eyenovia Key Balance Sheet Accounts

Eyenovia Key Income Statement Accounts

Eyenovia Key Cash Accounts

Eyenovia Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Eyenovia's current stock value. Our valuation model uses many indicators to compare Eyenovia value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eyenovia competition to find correlations between indicators driving Eyenovia's intrinsic value. More Info.Eyenovia is rated below average in return on equity category among its peers. It is rated # 5 in return on asset category among its peers . At this time, Eyenovia's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eyenovia's earnings, one of the primary drivers of an investment's value.

Eyenovia Systematic Risk

Today, most investors in Eyenovia Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Eyenovia's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Eyenovia growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Eyenovia help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Eyenovia. We use our internally-developed statistical techniques to arrive at the intrinsic value of Eyenovia based on widely used predictive technical indicators. In general, we focus on analyzing Eyenovia Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Eyenovia's daily price indicators and compare them against related drivers.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eyenovia. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Eyenovia Stock, please use our How to Invest in Eyenovia guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eyenovia. If investors know Eyenovia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eyenovia listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Eyenovia is measured differently than its book value, which is the value of Eyenovia that is recorded on the company's balance sheet. Investors also form their own opinion of Eyenovia's value that differs from its market value or its book value, called intrinsic value, which is Eyenovia's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eyenovia's market value can be influenced by many factors that don't directly affect Eyenovia's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Eyenovia's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eyenovia is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eyenovia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.